DIR 180 Commercial supply of a genetically modified COVID-19 vaccine – AstraZeneca Pty Ltd

See also:

DIR-180 Notice of decision to issue a licence for COVID-19 Vaccine:

Within the link:

http://www.ogtr.gov.au/internet/ogtr/publishing.nsf/Content/dir180